Maybe we'll have luck with this first Crispr company to go public. No matter the science, start-ups fail without cashola.
Pretty amazing technology, but might be years before profits. When's the trading fun begin?
Stock was split into NYLD and NYLD.A; shareholders get one NYLD.A for every NYLD, hence the price cut in half. YFinance doesn't have the new shares yet. Don't know what the difference is between the class A shares and the class C shares.
Sentiment: Strong Buy